Volume : 10, Issue : 06, June – 2023
Title:
22.UPDATED RECOMMENDATIONS FOR ASSESSMENT AND MANAGEMENT OF HYPERTENSION 2023
Authors :
Baraa Faiez Rajab, Alaa Elmutaz Mohamed Mahmoud, Fayez Salem Alenzi, Ghadi Abdulaziz Jastaniah, Dalia Farouk Eltayeb Ahmed, Haneen Anees Moumina, Angie Magdie Felimban, Sarah Mohammed Alnassar, Naglaa Abdallah Abdelrhman Siddig, Rami Sadakah A Mujahed, Ayman Naji Khallaf, Majed Mohammed Radhi Alsurayhi, Noor Haroon Sheikh, Hassan Omar Qahwaji
Abstract :
Introduction: Hypertension, commonly known as high blood pressure, is a prevalent health condition that affects millions of individuals worldwide. Given its association with cardiovascular diseases, it is crucial to effectively assess and manage hypertension to prevent complications and improve patient outcomes. This paper provides an overview of the current recommendations for the assessment and management of hypertension, including diagnostic criteria, risk stratification, lifestyle modifications, pharmacotherapy, and monitoring strategies. By implementing these evidence-based guidelines, healthcare professionals can optimize the management of hypertension and enhance patient well-being.
Aim of the Study: The present review aims to understand the diagnostic criteria, risk stratification, lifestyle and pharmacological management of hypertension in adults.
Methodology: The review is a comprehensive research of PUBMED from 2003 to 2023.
Conclusion: A chronic condition known as hypertension affects millions of individuals worldwide. Many people have hypertensive blood pressure while strolling around and are unaware of it. The management of hypertension involves changing one’s lifestyle, receiving pharmacological treatment, or using a combination of the two. Since hypertension affects numerous organ systems in the body, including the cardiovascular and renal systems, early diagnosis and treatment of the condition are essential to halting illness development. To ensure that the best course of treatment is followed, patients diagnosed with hypertension should regularly check in with their primary care physicians. To better meet the needs of patients, it is frequently necessary to alter drugs and lifestyle choices. Hypertension management is done individually, as patients have different risk factors and confounding variables that may contribute to their disease.
Keywords: ACE inhibitors, ARBs, Beta-blockers, calcium channel blockers, diuretic, hypertension, lifestyle modifications, low-sodium, management, risk-stratification, thiazide
Cite This Article:
Please cite this article in press Baraa Faiez Rajab et al, Updated Recommendations For Assessment And Management Of Hypertension 2023., Indo Am. J. P. Sci, 2023; 10 (06).
Number of Downloads : 10
References:
1. Whelton PK, et al. (2017) ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines,71(6):e13-e115.
2. Williams B, et al. (2018) ESC/ESH Guidelines for the management of arterial hypertension, 39(33):3021-3104.
3. National Institute for Health and Care Excellence (NICE) (2019). Hypertension in adults: diagnosis and management. Clinical guideline [CG127].
4. Parati G, et al. (2010) European Society of Hypertension practice guidelines for home blood pressure monitoring, 24(12):779-785.
5. Unger T, et al. (2020) International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 75(6):1334-1357.
6. Myers MG. (2004) White coat syndrome and the effect of observer presence on blood pressure measurement, 9(6):307-310.
7. Verberk WJ, et al. (2011) Definition of white-coat hypertension: Ambulatory blood pressure versus self-measured blood pressure, 29(12):2171-2178.
8. Mancia G, et al. (2013) ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J., 34(28):2159-2219.
9. Stergiou GS, et al. (2014) Masked hypertension: understanding its complexity. Eur J Clin Invest, 44(6):536-538.
10. Asayama K, et al. (2013) Masked hypertension: a review, 36(11):986-993.
11. Chobanian AV, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA, 289(19):2560-2572.
12. Muntner P, Carey RM, Gidding S, et al. (2018) Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline, 137:109.
13. Yoon SS, Gu Q, Nwankwo T, et al. (2015) Trends in blood pressure among adults with hypertension: United States, 2003 to 2012, 65:54.
14. Williams B, et al. (2018) ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension, 36(10):1953-2041.
15. Turnbull, F., Neal, B., Ninomiya, T., Algert, C., Arima, H., Barzi, F., Bulpitt, C., Chalmers, J., Fagard, R., Gleason, A., Heritier, S., Li, N., Perkovic, V., Woodward, M., & MacMahon, S. (2008). Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomized trials. BMJ (Clinical research ed.), 336(7653), 1121–1123.
16. Jamerson, K., Weber, M. A., Bakris, G. L., Dahlöf, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M., Velazquez, E. J., & ACCOMPLISH Trial Investigators (2008). Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. The New England journal of medicine, 359(23), 2417–2428.